News

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

0
Biochemistry laboratory research, Scientist or medical in lab coat holding test tube with Using Microscope reagent with drop of color liquid over glass equipment working at the laboratory.

Sartorius BIA Separations (BIA), a leading bio-chromatography company, now part of the international life science group Sartorius, and Exopharm Ltd. (ASX:EX1), a company at the forefront of transformative medicines using exosomes, or extracellular vesicles (EVs), today announced they had entered into a formal collaboration.

Bivalent mRNA vaccines could enhance protective efficacy against COVID-19

Previous article

Martian Meteorites Offer a Tantalizing Glimpse of the Red Planet

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News